Financials in USD. Standardized financial statements.
A compact view of how Surgical Science Sweden AB (publ) turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $989.85M | $884.09M | $882.85M | $802.54M | $366.78M | $104.80M | $101.52M | $65.70M | $57.98M | $51.80M |
| Revenue Growth? | +12.0% | +0.1% | +10.0% | +118.8% | +250.0% | +3.2% | +54.5% | +13.3% | +11.9% | 0.0% |
| Cost of Revenue? | $414.40M | $286.19M | $269.97M | $271.02M | $100.84M | $16.43M | $17.93M | -$6.22M | -$4.14M | -$6.30M |
| Gross Profit? | $575.46M | $597.90M | $612.88M | $531.52M | $265.94M | $88.36M | $83.58M | $71.92M | $62.12M | $58.10M |
| Gross Margin? | +58.1% | +67.6% | +69.4% | +66.2% | +72.5% | +84.3% | +82.3% | +109.5% | +107.1% | +112.2% |
| Operating Expenses? | $466.76M | $453.58M | $423.73M | $368.98M | $209.42M | $68.39M | $68.40M | $75.99M | $65.85M | $58.40M |
| Operating Income? | $108.70M | $144.32M | $189.15M | $162.54M | $88.75M | $19.97M | $15.18M | -$4.07M | -$3.73M | -$200,000 |
| EBITDA? | $191.86M | $169.65M | $214.29M | $271.30M | $115.05M | $30.22M | $30.36M | -$1.95M | -$2.25M | $8.59M |
| Income Before Tax | $99.89M | $158.09M | $268.26M | $208.17M | $65.80M | $19.66M | $15.25M | -$4.07M | -$3.91M | -$500,000 |
| Income Tax Expense | $33.24M | $26.45M | $34.29M | $20.20M | -$20.44M | $4.05M | $2.65M | $447,000 | -$1.65M | -$3.70M |
| Net Income? | $66.65M | $131.65M | $233.97M | $187.97M | $86.25M | $15.61M | $12.60M | -$4.52M | -$2.26M | $3.30M |
| EPS? | $1.29 | $2.58 | $4.59 | $3.70 | $2.03 | $0.45 | $0.45 | $-0.19 | $-0.12 | $0.14 |
| Diluted EPS? | $1.29 | $2.58 | $4.59 | $3.69 | $2.02 | $0.45 | $0.43 | $-0.18 | $-0.12 | $0.23 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality